InquirerPower interruption suspends classes in parts of Ilocos Sur on Nov. 17CBC NewsThe National | Carney arrives in China for meeting with XiPunchLagos festival turns bloody as cultists kill twoThe Jerusalem PostEpstein autopsy findings point to possible murder, forensic expert saysZDF heuteEntdecken Sie das ZDF-Nachrichtenstudio한겨레전두환 비자금 의혹 사건, 서울중수청이 맡는다El Comercio¿Cómo saber si una persona es buscada por la justicia? Así puedes consultar en Lima Digital매일경제동양화의 눈으로 그린 누드…몸이 낯선 풍경이 되다CNN TürkYeni "James Bond" belli olduBBC BusinessNvidia dismisses 'Bring Jensen Back' campaign as Trump backs effort to reinstate ex CEOGIGAZINE脱獄したPlayStation 4で90億パラメーターのAIモデルを毎秒最大43トークンで動作させる「Garlic LLM」が登場New Straits TimesBursa Malaysia opens lower as Nvidia concerns weigh on sentiment
The Daily Newsstand · Free, Always
Tuesday, November 17, 2026

African scientists target stomach ulcers, cancer with homegrown solutions

Translate

African medical experts are developing continent-specific guidelines for the diagnosis, prevention and treatment of Helicobacter pylori infections to reduce the burden of related conditions, including stomach ulcers and gastric cancer.

The initiative is being driven by the African Helicobacter and Microbiota Study Group, established to address challenges associated with H. pylori infections and gastric health within the context of Africa’s healthcare realities, including limited local funding, poor access to healthcare and inadequate diagnostic infrastructure.

The group is expected to advance discussions on the initiative at its second International Scientific Conference, scheduled to hold in Lusaka, Zambia, from November 27 to 28, 2026.

The two-day conference, which will take place at the Grand Palace Hotel, will bring together international experts, including Professor Emeritus Colm O’Morain and Professor Yoshio Yamaoka, who are expected to speak on emerging developments and research opportunities in H. pylori.

O’Morain, an Emeritus Professor of Medicine at Trinity College Dublin and Tallaght University Hospital, Ireland, will deliver the keynote address titled “The Next 40 Years of H. pylori – Opportunities and Challenges.”

Yamaoka, a physician, microbiologist and research specialist in Helicobacter and gastric cancer pathogens, will speak on “Collaborative Research in Africa: Current Progress and Future Perspective.”

In a statement sent to PUNCH Healthwise, the President of AHMSG, Professor Mashiko Setshedi, said the conference would also feature goodwill messages from the President of ZAGAN, Professor Peter Malfertheiner, and Professor Kelly of Richen Symposium.

The programme will include oral presentations, panel discussions, awards for the best oral presentation, the AHMSG presidential handover and a meeting of the group’s board members.

AHMSG was established and launched in Lagos, Nigeria, in 2022 through collaborative efforts to address challenges associated with H. pylori infections and gastric health across the continent.

Professor Stella Smith, Director of Research at the Nigerian Institute of Medical Research and a microbiologist, spearheaded the initiative and was appointed its founding president.

The founder noted that the group was formed after medical experts recognised that existing international medical guidelines did not adequately account for Africa’s distinct socioeconomic conditions, especially limited local funding, poor healthcare access and underdeveloped diagnostic infrastructure.

The group was therefore established to develop continent-specific guidelines for diagnosing, preventing and treating H. pylori infections.

It initially brought together medical scholars and board members from Nigeria, South Africa, Cameroon, Egypt, Kenya, Morocco, Senegal and Tanzania but has since expanded to include Zambia, Namibia and the Democratic Republic of Congo.

The group’s establishment received major sponsorship from a medical technology company based in China, Richen Medical Sciences.

The company’s Global Marketing Research and Development Director, Dr Attilio Citrino, said its support for the initiative reflected its commitment to scientific partnerships and improving early diagnosis and disease prevention.

He said cooperation with African medical and scientific communities presented an opportunity to advance gastrointestinal healthcare and create lasting benefits for patients.

“Medical innovation has real value only when it reaches patients and makes a difference in their lives. Our commitment is not simply to develop advanced diagnostic technologies, but to build meaningful scientific partnerships, share knowledge and support healthcare professionals in improving early diagnosis and disease prevention.

“We believe that cooperation with the African medical and scientific community represents an important opportunity to advance gastrointestinal healthcare and create lasting benefits for patients,” Citrino said.

Citrino and another executive at the company, Mr S. Jiangs, further said the company considered Africa an important region for sustainable scientific and healthcare collaborations.

They said the company aimed to strengthen relationships with African medical institutions, universities and healthcare professionals, while supporting greater awareness of H. pylori infection, earlier diagnosis and improved prevention of gastrointestinal diseases, including gastric cancer.

Richen Medical Science Group, headquartered in Beijing, China, was founded in 2002 and specialises in the research, development, manufacturing and commercialisation of diagnostic solutions.

With a focus on gastroenterology, the company develops non-invasive diagnostic technologies, including the Carbon-13 Urea Breath Test for detecting H. pylori infection, infrared spectrometry systems and hydrogen and methane breath-testing technologies for assessing gastrointestinal disorders.

The company also supports clinical research, scientific education and collaboration with academic institutions and professional organisations, including its longstanding partnership with the European Helicobacter and Microbiota Study Group.

View the original on Punch →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.